Work

Cardiovascular biomarkers in dementia risk prediction

Year: 2017
Type: dissertation
Study design: Observational Study
Abstract: Dementia, caused by neurodegeneration, has a considerable socioeconomic influence on patients, their families and on society as a whole.The magnitude of this problem is expected to grow in the coming decades.These neurodegenerative processes have multiple aetiologies, Alzheimer's disease (AD) being the most prevalent type, but cooccurrence of different pathogenic processes is common.The association of cardiovascular risk factors with dementia is being increasingly recognized.High total serum cholesterol, diabetes and hypertension are considered to be risk factors for dementia, yet in recent years the preventive potential has not been realized.One possible reason for this is the lack of proper clinical risk stratification for dementia while untargeted risk management is not efficient.Also, the changing effect of risk factors at different ages may also influence the results of preventive measures.The purpose of this study was to investigate the associations of different cardiovascular biomarkers with incident dementia and AD and to estimate the benefits of these risk factors in the risk prediction of dementia or AD.Tested biomarkers were Nterminal probrain natriuretic peptide (NTproBNP), cardiac troponinI (hsTnI), apolipoprotein AI (apo AI), HDL cholesterol (HDLC) and apolipoprotein B (apo B).We also examined the associations between incident dementia and biomarkers determined mainly by nuclear magnetic resonance (NMR) metabolomics platform.This biomarker platform included several small molecular metabolites, lipids and lipoprotein subfraction lipids.For NTproBNP and hsTnI analyses we used the FINRISK 1997 population based health examination survey with 7,150 Finnish participants aged between 25 and 74 years (Studies III).Apo AI, HDLC and apo B analyses were conducted in the FINRISK 1997 and 2002 cohorts with 13,275 participants (Study III).For metabolomic analyses we used altogether eight independent study cohorts with 22,623 participants aged over 40 years (Study IV) and one of the eight cohorts was FINRISK 1997.In the metabolomic study, apo AI, HDLC and apo B results were replicated as a part of the NMR metabolomics platform.We observed NTproBNP and hsTnI to be associated with incident dementia independently of other dementia risk factors.They provided moderate but statistically significant discrimination and reclassification benefit over and above VI traditional dementia risk factors.We observed NTproBNP also to be associated with incident AD.In NMR metabolomics analyses three branched chain amino acids (BCAA) leucine, isoleucine and valine were associated with lower dementia risk as were creatinine and two lipoprotein subfraction lipids: total cholesterol in small VLDL (SVLDLC) and total triglycerides to total lipids ratio in very large VLDL (XLVLDLTG%).Cholesterol esters relative to total lipids in large HDL (LHDLCE%) and total cholesterol to total lipids ratio in very large VLDL (XLVLDLC%) were associated with higher dementia risk.However, we observed no other associations in altogether 228 measured biomarkers including amino acids, fatty acids and saturation, fluid balance, glycolysis related metabolites, ketone bodies, inflammation markers, glycerides and phospholipids, apolipoproteins, cholesterols, lipoprotein particle sizes and other lipoprotein subfraction lipids.Apo AI, HDLC and apo B were not associated with incident dementia and AD in the FINRISK cohorts.This was also confirmed in these independent metabolomic study cohorts.In conclusion, cardiovascular biomarkers NTproBNP and hsTnI are potentially useful in dementia risk prediction, unlike markers such as apo AI, HDLC and apo B. In addition to NTproBNP and hsTnI, BCAAs, HDL and VLDLlipoprotein subfraction lipids may offer new insights into the pathogenesis of dementia and AD.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W3161905566
Cites: 241
Cited by:
Related to: 10